Major weight loss, pain relief seen with Eli Lilly's next-gen drug in late-stage trial

Eli Lilly's experimental drug, retatrutide, showed strong results in a late-stage trial, helping patients lose nearly 29% of ...
The New York Sun

Zepbound Maker Eli Lilly Reports Patients Achieved Dramatic Weight Loss in Study of Newest Obesity Drug

Some patients dropped out of the trial early because they had lost so much weight.

Private health insurance costs are going up. A complete guide to your coverage options

Private health insurance premiums will be going up in 2026 — in some cases, by a lot. Congressional Democrats and Republicans ...
The Pricer

How Much Does Retatrutide Cost?

Retatrutide is an investigational triple agonist developed by Eli Lilly that targets GLP-1, GIP and glucagon receptors, and ...
TMCnet

Crux Adds Obesity Management Medicine to its Newly Launched Employer Benefit Platform

Crux, the first no-fee benefits platform working directly with pharmaceutical companies and employers of all sizes to expand transparent and affordable access to transformative FDA-approved ...
CNBC

Half of shoppers are relying on BNPL this holiday season, but here are 3 alternatives

If you're planning on using buy now, pay later (BNPL) to cover your holiday shopping this year — and half of shoppers are, per PayPal — know that there are alternative financing options out there ...